India Begins Phase 3 Clinical Trials for Indigenous Dengue Vaccine
New Delhi: The Indian Council of Medical Research (ICMR) and Panacea Biotec have commenced the first-ever Phase 3 clinical trial for an indigenous dengue vaccine in India. The trial will assess the effectiveness of DengiAll, a tetravalent…